Annals of Indian Academy of Neurology
REVIEW ARTICLE
Year
: 2006  |  Volume : 9  |  Issue : 4  |  Page : 207--216

Controlled release formulations in neurology practice


JK Pandit, S Singh, MS Muthu 
 Department of Pharmaceutics, Institute of Technology, Banaras Hindu University, Varanasi - 221 005, India

Correspondence Address:
J K Pandit
Department of Pharmaceutics, Institute of Technology, Banaras Hindu University, Varanasi - 221 005
India

Recently, controlled release (CR) pharmaceutical products have become a very useful tool in medical practice, offering a wide range of actual and perceived advantages to the patient. A CR product requires numerous considerations, like drugs suitable for CR formulations, techniques of fabrication and evaluation, factors affecting bioavailability of the parent drug, before it can actually be claimed to provide the purported benefits. Such complex considerations fall under the domain of pharmaceutical experts and clinicians, naturally, are not sufficiently aware and updated about these products and their biological consequences. Various CR formulations used in neurological practice are discussed in the present review. The clinical studies of the conventional and CR dosage form of the drugs used in neurology practice reflect the advantages of prescribing CR formulations over the conventional dosage forms.


How to cite this article:
Pandit J K, Singh S, Muthu M S. Controlled release formulations in neurology practice.Ann Indian Acad Neurol 2006;9:207-216


How to cite this URL:
Pandit J K, Singh S, Muthu M S. Controlled release formulations in neurology practice. Ann Indian Acad Neurol [serial online] 2006 [cited 2021 Sep 22 ];9:207-216
Available from: https://www.annalsofian.org/article.asp?issn=0972-2327;year=2006;volume=9;issue=4;spage=207;epage=216;aulast=Pandit;type=0